A combination treatment of low-dose dexamethasone and aspirin-triggered resolvin D1 reduces Sjögren syndrome–like features in a mouse model

BACKGROUND. Sjögren syndrome (SS) is an autoimmune disease characterized by lymphocytic infiltration and diminished secretory function of the salivary glands. Dexamethasone (DEX) resolves dry mouth and lymphocytic infiltration; however, this treatment is difficult to maintain because of multiple adv...

Descripción completa

Detalles Bibliográficos
Autores principales: dos Santos, Harim Tavares, Maslow, Frank, Nam, Kihoon, Trump, Bryan, Weisman, Gary A., Baker, Olga J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448398/
https://www.ncbi.nlm.nih.gov/pubmed/37622089
http://dx.doi.org/10.1016/j.jfscie.2022.100016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448398/
https://www.ncbi.nlm.nih.gov/pubmed/37622089
http://dx.doi.org/10.1016/j.jfscie.2022.100016

Ejemplares similares